Gray platelet syndrome. A variety of qualitative platelet disorder.
D000244:Adenosine Diphosphate / Q000032:analysis / Q000494:pharmacology; D000255:Adenosine Triphosphate / Q000032:analysis; D001791:Blood Platelet Disorders / Q000175:diagnosis* / Q000628:therapy; D001792:Blood Platelets / Q000032:analysis / Q000187:drug effects / Q000503:physiopathology; D001798:Blood Proteins / Q000032:analysis; D002648:Child; D002849:Chromatography, Gas; D002855:Chromatography, Thin Layer; D003094:Collagen / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D005227:Fatty Acids / Q000032:analysis; D005340:Fibrinogen / Q000032:analysis; D006487:Hemostasis; D006801:Humans; D008297:Male; D008854:Microscopy, Electron; D010714:Phosphatidylethanolamines / Q000032:analysis; D010743:Phospholipids / Q000032:analysis; D010973:Platelet Adhesiveness; D011241:Prednisone / Q000627:therapeutic use; D012877:Skin Manifestations; D013154:Spleen / Q000473:pathology; D013156:Splenectomy
D001798:Blood Proteins; D005227:Fatty Acids; D010714:Phosphatidylethanolamines; D010743:Phospholipids; D000244:Adenosine Diphosphate; D000255:Adenosine Triphosphate; D005340:Fibrinogen; D003094:Collagen; D011241:Prednisone; D004837:Epinephrine